Corticosteroid tapering is a safe approach in patients with relapsed or refractory multiple myeloma receiving subcutaneous daratumumab: part 3 of the open-label, multicenter, phase 1b PAVO study

  1. Nahi, H.
  2. Usmani, S.Z.
  3. Mateos, M.-V.
  4. van de Donk, N.W.C.J.
  5. Oriol, A.
  6. Plesner, T.
  7. Bandyopadhyay, N.
  8. Hellemans, P.
  9. Tromp, B.
  10. Nnane, I.
  11. Zemlickis, D.
  12. Chari, A.
  13. Moreau, P.
Zeitschrift:
Leukemia and Lymphoma

ISSN: 1029-2403,  1042-8194

Datum der Publikation: 2023

Ausgabe: 64

Nummer: 2

Seiten: 468-472

Art: Brief

DOI: 10.1080/10428194.2022.2148221 GOOGLE SCHOLAR lock_openOpen Access editor